Lymphatic Vessels in Tumor Dissemination versus Immunotherapy

Show full item record



Permalink

http://hdl.handle.net/10138/331980

Citation

Vaahtomeri , K & Alitalo , K 2020 , ' Lymphatic Vessels in Tumor Dissemination versus Immunotherapy ' , Cancer Research , vol. 80 , no. 17 , pp. 3463-3465 . https://doi.org/10.1158/0008-5472.CAN-20-0156

Title: Lymphatic Vessels in Tumor Dissemination versus Immunotherapy
Author: Vaahtomeri, Kari; Alitalo, Kari
Contributor organization: Cell Communication
Staff Services
CAN-PRO - Translational Cancer Medicine Program
University of Helsinki
HUSLAB
Kari Alitalo / Principal Investigator
Research Programs Unit
Digital Precision Cancer Medicine (iCAN)
Date: 2020-09-01
Language: eng
Number of pages: 3
Belongs to series: Cancer Research
ISSN: 0008-5472
DOI: https://doi.org/10.1158/0008-5472.CAN-20-0156
URI: http://hdl.handle.net/10138/331980
Abstract: During the growth of various cancers, primary tumors can escape antitumor immune responses of their host and eventually disseminate into distant organs. Peritumoral lymphatic vessels connect the primary tumor to lymph nodes, facilitating tumor entry into lymph nodes, systemic circulation, and metastasis. Lymph node metastases that occur frequently provide sites of tumor cell spread, whereas tumor antigen transfer into and presentation in tumor-draining lymph nodes induce activation of tumor-specific T-lymphocyte responses that can result in cytolytic targeting of the tumor. Here, we discuss the recently emerged controversial role of the lymphatic vessels in tumor dissemination and cancer immunotherapy.
Subject: BLOOD-VESSELS
METASTASES
NODE
EXIT
3122 Cancers
Peer reviewed: No
Rights: unspecified
Usage restriction: openAccess
Self-archived version: acceptedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
Vaahtomeri_Alitalo_Final_draft.pdf 157.8Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record